On 3 Nov., 2015, Star Lake Bioscience Co., Inc. Zhaoqing Guangdong (Star Lake Bioscience) announced that it had decided to stop its major asset reorganization. Its stock resumed transaction from the day onward.

Star Lake Bioscience Co., Inc. Zhaoqing Guangdong (Star Lake Bioscience) recently published its Q3 2014 report, according to which in the first three quarters of 2014, the company underperformed on the whole. It realized a revenue of USD96.7 million, down by 12.29% year on year while its net profit attributable to its shareholders was –USD36.4 million, falling by 442% year on year.